Macquarie Group Ltd. reduced its position in shares of Intuitive Surgical Inc. (NASDAQ:ISRG) by 31.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 19,680 shares of the company’s stock after selling 9,170 shares during the period. Macquarie Group Ltd. owned about 0.05% of Intuitive Surgical worth $13,017,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the stock. AGF Investments Inc. purchased a new stake in shares of Intuitive Surgical during the second quarter worth $33,766,000. Strs Ohio increased its stake in shares of Intuitive Surgical by 6,226.9% in the second quarter. Strs Ohio now owns 47,895 shares of the company’s stock worth $31,678,000 after buying an additional 47,138 shares during the period. Retirement Systems of Alabama increased its stake in shares of Intuitive Surgical by 2.7% in the second quarter. Retirement Systems of Alabama now owns 19,404 shares of the company’s stock worth $12,834,000 after buying an additional 508 shares during the period. Cookson Peirce & Co. Inc. increased its stake in shares of Intuitive Surgical by 3.3% in the second quarter. Cookson Peirce & Co. Inc. now owns 36,371 shares of the company’s stock worth $24,056,000 after buying an additional 1,148 shares during the period. Finally, Bourne Lent Asset Management Inc. increased its stake in shares of Intuitive Surgical by 4.2% in the second quarter. Bourne Lent Asset Management Inc. now owns 4,961 shares of the company’s stock worth $3,281,000 after buying an additional 200 shares during the period. Institutional investors and hedge funds own 90.64% of the company’s stock.

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Shares of Intuitive Surgical Inc. (NASDAQ:ISRG) traded down 1.0763% during midday trading on Wednesday, hitting $643.3105. The stock had a trading volume of 120,039 shares. Intuitive Surgical Inc. has a one year low of $502.01 and a one year high of $727.25. The firm has a market capitalization of $24.93 billion, a PE ratio of 34.6985 and a beta of 0.55. The firm’s 50-day moving average price is $671.47 and its 200-day moving average price is $673.58.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 18th. The company reported $6.19 earnings per share for the quarter, beating the Zacks’ consensus estimate of $5.13 by $1.06. Intuitive Surgical had a return on equity of 15.02% and a net margin of 27.51%. The firm earned $682.90 million during the quarter, compared to analysts’ expectations of $650.49 million. During the same period last year, the firm posted $5.24 EPS. The business’s revenue was up 15.8% on a year-over-year basis. On average, equities analysts predict that Intuitive Surgical Inc. will post $22.19 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Intuitive Surgical Inc. (ISRG) Shares Sold by Macquarie Group Ltd.” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2016/11/30/intuitive-surgical-inc-isrg-shares-sold-by-macquarie-group-ltd.html.

A number of equities research analysts have recently weighed in on ISRG shares. Raymond James Financial Inc. started coverage on Intuitive Surgical in a report on Friday, August 26th. They issued an “outperform” rating for the company. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $753.00 price objective for the company in a research note on Wednesday, September 14th. Wells Fargo & Co. initiated coverage on Intuitive Surgical in a research note on Thursday, October 13th. They set an “outperform” rating for the company. BTIG Research restated a “hold” rating on shares of Intuitive Surgical in a research note on Tuesday, September 20th. Finally, JPMorgan Chase & Co. restated a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, September 20th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. Intuitive Surgical presently has a consensus rating of “Buy” and an average price target of $729.50.

In related news, CEO Gary S. Guthart sold 13,515 shares of the firm’s stock in a transaction on Monday, November 7th. The stock was sold at an average price of $680.68, for a total transaction of $9,199,390.20. Following the completion of the sale, the chief executive officer now directly owns 82,880 shares of the company’s stock, valued at approximately $56,414,758.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Lonnie M. Smith sold 275 shares of the firm’s stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $646.50, for a total value of $177,787.50. Following the sale, the director now directly owns 235,890 shares of the company’s stock, valued at $152,502,885. The disclosure for this sale can be found here. Corporate insiders own 3.10% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.